Work

Phase I dose-escalation trial investigating the safety and tolerability of EPO906 plus gemcitabine in patients with advanced cancer

Year: 2004

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2004.22.14_suppl.3100

Authors: J. J. Rinehart, J. D. Rothermel, J. Anderson, P. Lorusso

Institution: University of Alabama at Birmingham

Language: English

Topic: Cancer Treatment and Pharmacology

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2596691004

Cites:

Cited by: 8

Related to: 10